Empliciti (Bristol-Myers Squibb/AbbVie): Global Drug Overview & Outlook Report 2017-2026 - ResearchAndMarkets.com

DUBLIN--()--The "Empliciti" report has been added to ResearchAndMarkets.com's offering.

Empliciti (elotuzumab; Bristol-Myers Squibb/AbbVie) is a monoclonal antibody that targets the signaling lymphocytic activation molecule family, member 7 (SLAMF7), also called CS1.

This cell-surface glycoprotein is expressed in high levels on multiple myeloma (MM) cells and normal plasma cells.

It is also expressed on natural killer (NK) cells where it functions as an activating receptor. Empliciti induces MM cell death by direct activation of NK cells and through antibody-dependent NK cell-mediated cytotoxicity.

Key Topics Covered

  1. Drug Overview
  2. Product Profiles
  3. Empliciti: Multiple myeloma

List of Figures

Figure 1: Empliciti for multiple myeloma - SWOT analysis

Figure 2: The authors drug assessment summary of Empliciti for multiple myeloma

Figure 3: Empliciti sales for multiple myeloma across the US, Japan, and five major EU markets, by country, 2017-26

List of Tables

Table 1: Empliciti drug profile

Table 2: Empliciti pivotal trial data in multiple myeloma

Table 3: Empliciti early-phase trial data in multiple myeloma

Table 4: Empliciti ongoing late-phase clinical trials in multiple myeloma

Table 5: Empliciti sales for multiple myeloma across the US, Japan, and five major EU markets, by country ($m), 2017-26

Table 6: Patients treated with Empliciti across the US, Japan, and five major EU markets, by country, 2017-26

For more information about this report visit https://www.researchandmarkets.com/r/6zou0j

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Leukemia Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Leukemia Drugs